COMPOSITIONS AND METHODS FOR TREATING DIABETES
The present disclosure is a compound, a method of making the compound and method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of treating prediabetes, diabetes, insulin resistance or metabolic syndrome. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least vitamin D, gamma tocopherol, niacin, folate, chromium, zinc, magnesium, potassium, bilberry, resveratrol, holy basil and berberine, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule, powder, liquid or tablet.
1 . A composition for treating diabetes-related disorders, comprising:
between about 1,000 and about 10,000 IU of vitamin D3;
between about 20 to about 200 mg of vitamin E;
between about 5 and about 500 mg of niacin;
between about 25 mcg and about 1,000 mcg of folate;
between about 50 and about 500 mg of magnesium;
between about 1 and about 40 mg of zinc;
between about 100 and about 500 mcg of chromium;
between about 30 and about 300 mg of potassium;
between about 50 and about 1,000 mg of berberine;
between about 10 and about 1,000 mg of Holy basil leaf;
between about 25 and about 800 mg of resveratrol; and
between about 10 and about 400 mg of bilberry.
2 . The composition of claim 1 , wherein the composition is provided as a dietary supplement.
3 . The composition of claim 1 , wherein the composition is administered orally in the form of a capsule.
4 . The composition of claim 1 , wherein the composition is administered orally in the form of a tablet.
5 . The composition of claim 1 , wherein the composition is substantially free of at least one of milk, casein, egg, shellfish, tree nut, peanut, wheat, gluten, artificial flavors, artificial colors, preservative, magnesium stearate, and soybean.
6 . The composition of claim 1 , further comprising at least one palatability agent, and wherein the palatability agent is selected from the group consisting of a plant oil, a plant hydrolysate, yeast, a yeast hydrolysate, and combinations thereof
7 . The composition of claim 1 , wherein the vitamin D is cholecalciferol, and comprising about 1,000 mg of cholecalciferol.
8 . The composition of claim 1 , wherein the vitamin E is gamma tocopherol, and the composition comprises about 300 IU of gamma tocopherol.
9 . The composition of claim 1 , comprising about 20 mg of niacin.
10 . The composition of claim 1 , wherein the folate is Metafolin™, and wherein the composition comprises about 200 mg of the Metafolin™
11 . The composition of claim 1 , wherein the magnesium is magnesium malate, and wherein the composition comprises about 125 mg of magnesium malate.
12 . The composition of claim 1 , wherein the zinc is zinc bisglycinate chelate, and wherein the composition comprises about 5 mg of zinc bisglycinate chelate.
13 . The composition of claim 1 , wherein the chromium is chromium nicotinate glycerinate chelate, and wherein the composition comprises about 250 mcg of chromium nicotinate glycerinate chelate.
14 . The composition of claim 1 , wherein the potassium is tripotassium citrate monohydrate, and wherein the composition comprises about 90 mg of tripotassium citrate monohydrate.
15 . The composition of claim 1 , comprising about 25 mg of bilberry.
16 . The composition of claim 1 , comprising about 150 mg of berberine.
17 . The composition of claim 1 , comprising about 50 mg of Holy Basil extract.
18 . The composition of claim 1 , wherein the resveratrol is a trans isomer, and the composition comprises about 50 mg of the trans isomer of the resveratrol.
19 . A composition for treating diabetes, comprising:
about 1,000 mg of vitamin D;
about 300 IU of gamma tocopherol;
about 20 mg of niacin;
about 200 mg of folate;
about 125 mg of magnesium malate;
about 5 mg of zinc bisglycinate chelate;
about 250 mcg of chromium nicotinate glycerinate chelate;
about 90 mg of tripotassium citrate monohydrate;
about 25 mg of bilberry;
about 150 mg of berberine;
about 50 mg of Holy Basil extract; and
about 50 mg of a trans isomer of resveratrol.
20 . A method to treat diabetes, comprising:
administering the following to a patient:
between about 1,000 and about 10,000 IU of vitamin D3;
between about 20 to about 200 mg of vitamin E;
between about 5 and about 500 mg of niacin;
between about 25 mcg and about 1,000 mcg of folate;
between about 50 and about 500 mg of magnesium;
between about 1 and about 40 mg of zinc;
between about 100 and about 500 mcg of chromium;
between about 30 and about 300 mg of potassium;
between about 50 and about 1,000 mg of berberine;
between about 10 and about 1,000 mg of Holy basil leaf;
between about 25 and about 800 mg of resveratrol; and
between about 10 and about 400 mg of bilberry.